News about Market

Lung Cancer Canada and Boehringer Ingelheim Canada Partner to Advance NSCLC Diagnostics

Lung Cancer Canada and Boehringer Ingelheim have launched a two-stage initiative to accelerate innovation in NSCLC diagnostics. The effort begins with a national Diagnostic Innovation Lab to identify key barriers in diagnosis, followed by an innovation challenge seeking solutions to close those gaps.

Market | 29/11/2025 | By Dineshwori |  284

SK Biopharmaceuticals Expands Radiopharma Portfolio with New WARF In-Licensing

SK Biopharmaceuticals has in-licensed a second radiopharmaceutical therapy candidate from the Wisconsin Alumni Research Foundation (WARF), further strengthening its pipeline and advancing its strategy to build an integrated, globally competitive radiotherapeutics portfolio.

Market | 29/11/2025 | By Dineshwori |  382

Cipla Launches India's First Dedicated Lung Health Diagnostics Centre in Delhi

Cipla has opened the country’s first dedicated lung diagnostics centre in Delhi, equipped to conduct over 60 tests across respiratory function, microbial studies, immune profiling, blood chemistry and imaging.

Market | 29/11/2025 | By Dineshwori |  312

GV20 Therapeutics Hits Milestone in ADC Collaboration with Mitsubishi Tanabe Pharma

GV20 Therapeutics has secured a milestone payment from Mitsubishi Tanabe Pharma under their 2025 collaboration to develop the first-in-class Antibody Drug Conjugates (ADCs) using GV20’s STEAD AI–discovered tumour-targeting antibodies.

Market | 28/11/2025 | By Dineshwori |  419

Exyte Completes Pharmaplan's Integration

The completed integration of Pharmaplan marks a major milestone in Exyte’s strategy to build a leading European player in life sciences engineering and strengthen collaboration with the region’s biotechnology and pharmaceutical industries.

Market | 28/11/2025 | By Dineshwori |  352

Crane NXT to Acquire Antares Vision, Plans Take-Private Deal

Crane NXT, a leading industrial technology company, announced that it has signed definitive agreements to acquire a significant stake in Antares Vision S.p.A., with plans to take the company private.

Market | 28/11/2025 | By Darshana |  211

Eris Lifesciences to Increase Its Stake in Swiss Parenterals

Eris Lifesciences has announced plans to consolidate its stake in Swiss Parenterals, while bringing Naishadh Shah on board as a top-10 shareholder and part of the management, strengthening its leadership and long-term strategic vision.

Market | 27/11/2025 | By Dineshwori |  166

Revvity to Acquire ACD/Labs to Strengthen Scientific Software Portfolio

Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software that supports analytical characterization and molecular design for pharmaceutical and material sciences.

Market | 25/11/2025 | By Darshana |  380

Aurobindo Pharma's China Facility Running at Loss, Eyes Break-Even by Q4

The company’s CFO, S. Subramanian, indicated that while the plant is operating below margin, it is ramping up production and is on track to contribute positively to the company’s EBITDA in the near future.

Market | 24/11/2025 | By Darshana |  182

Steriline Marks 100th Installation in India as It Returns to CPHI & PMEC

With approximately 20 years of activity in the Indian market, Steriline has now reached 100 full line installations and aims for double-digit annual installations in 2026.

Market | 21/11/2025 | By Dineshwori |  176